New radiation cocktail aims to cut prostate cancer treatment time
NCT ID NCT01655836
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This early-phase trial tests combining two types of radiation therapy for men with intermediate-risk prostate cancer. First, a small radioactive source is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly focused external radiation (SBRT). The goal is to see if this shorter, more intense approach is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (high dose rate brachytherapy and stereotactic body radiation therapy)
What this could lead to
If successful, this could lead to a shorter, more precise radiation treatment for prostate cancer with fewer side effects.
What could go wrong
This is a very early phase 1 trial with only 42 participants, so safety and effectiveness are not yet proven. There may be unexpected side effects from combining two radiation methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.